Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LSM5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ZDBF2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SCOC - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MSANTD3-TMEFF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
C2orf69 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MORF4L1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DSTN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RAC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
XIAP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KLHL24 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PPIP5K2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
VPS13A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MRM2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ANKRD36BP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ERI2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATP9B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C4orf32 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KRCC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
VBP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on